Vineet Laboratories Ltd
NSE:VINEETLAB
Vineet Laboratories Ltd
NSE:VINEETLAB
Price:
32.8
INR
0.95%
Market Closed
Market Cap:
₹630.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vineet Laboratories Ltd
NSE:VINEETLAB
|
IN |
|
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
IN |
|
Janome Corp
TSE:6445
|
JP |
|
Cenkos Securities PLC
LSE:CNKS
|
UK |
Income Statement
Earnings Waterfall
Vineet Laboratories Ltd
Vineet Laboratories Ltd
Income Statement
Vineet Laboratories Ltd
Vineet Laboratories Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
15
|
0
|
0
|
0
|
3
|
7
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
| Revenue |
1 912
N/A
|
1 823
-5%
|
1 823
0%
|
2 107
+16%
|
2 123
+1%
|
1 506
-29%
|
609
-60%
|
798
+31%
|
979
+23%
|
750
-23%
|
586
-22%
|
570
-3%
|
546
-4%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(1 456)
|
(1 349)
|
(1 410)
|
(1 708)
|
(1 723)
|
(1 139)
|
(454)
|
(588)
|
(761)
|
(702)
|
(559)
|
(543)
|
(468)
|
|
| Gross Profit |
456
N/A
|
474
+4%
|
413
-13%
|
399
-3%
|
400
+0%
|
367
-8%
|
49
-87%
|
104
+113%
|
113
+8%
|
48
-58%
|
27
-44%
|
28
+3%
|
78
+182%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(344)
|
(351)
|
(350)
|
(343)
|
(347)
|
(320)
|
(142)
|
(207)
|
(263)
|
(235)
|
(204)
|
(170)
|
(154)
|
|
| Selling, General & Administrative |
(49)
|
(46)
|
(46)
|
(55)
|
(60)
|
(64)
|
(33)
|
(46)
|
(58)
|
(53)
|
(50)
|
(45)
|
(43)
|
|
| Depreciation & Amortization |
(20)
|
(21)
|
(23)
|
(23)
|
(24)
|
(25)
|
(13)
|
(19)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
|
| Other Operating Expenses |
(275)
|
(284)
|
(281)
|
(265)
|
(263)
|
(231)
|
(96)
|
(141)
|
(179)
|
(157)
|
(130)
|
(101)
|
(86)
|
|
| Operating Income |
112
N/A
|
124
+10%
|
63
-49%
|
56
-11%
|
53
-6%
|
47
-11%
|
13
-72%
|
4
-71%
|
(44)
N/A
|
(188)
-325%
|
(177)
+6%
|
(143)
+20%
|
(76)
+47%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(16)
|
(30)
|
(31)
|
(38)
|
(3)
|
(7)
|
(11)
|
(21)
|
(31)
|
(5)
|
(35)
|
(47)
|
(48)
|
|
| Total Other Income |
(3)
|
3
|
2
|
2
|
(29)
|
(36)
|
(10)
|
(8)
|
(7)
|
(15)
|
17
|
15
|
15
|
|
| Pre-Tax Income |
94
N/A
|
97
+4%
|
34
-65%
|
21
-40%
|
20
-1%
|
4
-82%
|
(8)
N/A
|
(25)
-213%
|
(82)
-228%
|
(208)
-153%
|
(195)
+6%
|
(174)
+11%
|
(109)
+37%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
(27)
|
(33)
|
(25)
|
(11)
|
(8)
|
7
|
5
|
4
|
4
|
6
|
6
|
7
|
8
|
|
| Income from Continuing Operations |
66
|
64
|
10
|
10
|
13
|
10
|
(2)
|
(20)
|
(77)
|
(202)
|
(189)
|
(167)
|
(101)
|
|
| Net Income (Common) |
66
N/A
|
64
-4%
|
10
-85%
|
10
+3%
|
13
+28%
|
10
-18%
|
(2)
N/A
|
(20)
-900%
|
(77)
-285%
|
(202)
-162%
|
(189)
+7%
|
(167)
+12%
|
(101)
+39%
|
|
| EPS (Diluted) |
7.2
N/A
|
6.92
-4%
|
1.04
-85%
|
1.07
+3%
|
1.15
+7%
|
0.94
-18%
|
-0.21
N/A
|
-2.16
-929%
|
-8.35
-287%
|
-18.48
-121%
|
-17.27
+7%
|
-15.08
+13%
|
-9.23
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
